Brief: Lyell Immunopharma Reports Second Quarter 2021 Financial Results And Business Highlights
12/08/2021 23:25
Aug 12 (Reuters) - Lyell Immunopharma Inc LYEL.O :
* LYELL IMMUNOPHARMA REPORTS SECOND QUARTER 2021 FINANCIAL
RESULTS
AND BUSINESS HIGHLIGHTS
* LYELL IMMUNOPHARMA INC - QTRLY NET LOSS WAS $62.6 MILLION
Source text for Eikon: ID:nGNX6Yd7fS
Further company coverage: LYEL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lyell Immunopharma
See all newsBrief: Lyell Immunopharma Says Additional Clinical Data And End-Of-Phase 1 FDA Meeting Expected In 2027
Lyell Immunopharma, Inc. reports results for the quarter ended June 30 - Earnings Summary
Lyell Immunopharma, Inc. expected to post a loss of $2.08 a share - Earnings Preview
Brief: Lyell Immunopharma Q2 Operating Expenses USD 47.341 Million
Brief: Lyell Immunopharma Shows Updated Safety Data For Ronde-Cel In Patients With Large B-Cell Lymphoma